EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Regulatory framework for polymer-based nanotherapeutics in clinical translation

Federico Stucchi, Min Li, Giuseppe Castellano, Francesco Cellesi

Frontiers in Bioengineering and Biotechnology · 21.01.2026 · 14

DOI: 10.3389/fbioe.2026.1735885 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Bioengineering and Biotechnology, online erschienen am 21.01.2026. Verfasst von Federico Stucchi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Materials and Chemical Engineering "Giulio Natta", Politecnico di Milano, Milan, Italy. Die Arbeit wurde bisher 82-mal zitiert (Crossref) und nennt 152 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polymer-based nanotherapeutics (PNs) have emerged as versatile drug delivery platforms offering controlled release, targeted delivery, and improved pharmacokinetics across therapeutic areas. However, their structural complexity and nanoscale behavior pose significant regulatory challenges. Current frameworks still evaluate PNs under conventional pharmaceutical and biological regulations, overlooking nanospecific properties and leading to case-by-case assessments. This review examines critical quality attributes, analytical requirements, and gaps in standardization that hinder clinical translation. Key issues include inadequate characterization of the physicochemical properties, scalability of manufacturing, and limited predictability of in vivo performance. Highlighting the mismatch between nanoscale properties and existing regulatory expectations, this review underscores the need for a harmonized, science-driven framework to ensure safety, efficacy, and global acceptance of PNs.

Schlagwörter

Stichwörter der Autor:innen

clinical translationcritical quality attributesnanomedicine policypolymer conjugatespolymeric nanoparticlesquality by bench-to-bedside designregulatory framework

Autor:innen und Institutionen

  • Department of Chemistry, Materials and Chemical Engineering "Giulio Natta", Politecnico di Milano, Milan, Italy.
  • Renal Research Laboratory, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Unit of Nephrology, Dialysis and Renal Transplant, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.

Zitieren

APA

Stucchi, F., Li, M., Castellano, G., & Cellesi, F. (2026). Regulatory framework for polymer-based nanotherapeutics in clinical translation. Frontiers in Bioengineering and Biotechnology, 14. https://doi.org/10.3389/fbioe.2026.1735885

Vancouver

Stucchi F, Li M, Castellano G, Cellesi F. Regulatory framework for polymer-based nanotherapeutics in clinical translation. Frontiers in Bioengineering and Biotechnology. 2026;14. doi:10.3389/fbioe.2026.1735885

BibTeX
@article{Stucchi2026,
  author = {Stucchi, Federico and Li, Min and Castellano, Giuseppe and Cellesi, Francesco},
  title = {Regulatory framework for polymer-based nanotherapeutics in clinical translation},
  journal = {Frontiers in Bioengineering and Biotechnology},
  year = {2026},
  volume = {14},
  doi = {10.3389/fbioe.2026.1735885}
}
Kostenlos starten →